You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Qingying Wang1, Mingli Chen1, Yinheng Zhu1
1Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, TX 75390, United States of America.
View abstract on PubMed
Mid-Range Proton Arc Therapy (MRPAT) offers an efficient solution for proton arc therapy, improving delivery speed and containing biological uncertainties within the target. This novel approach enhances normal tissue sparing and is practical for clinical implementation.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: